(NASDAQ:SBRA), some interesting facts appear regarding these companies. As of April 28th, there was short interest totalling 6,116,085 shares, a decline of 17.2% from the April 13th total of 7,389,917 shares. 1,566,192 shares of the company's stock traded hands. HCP has the outstanding shares of 475.23and its EPS growth ratio for the past five years was -9.10%.
Investors are feeling more bearish on Sabra Healthcare REIT, Inc. of late as evidenced by the change in short interest. Volume on the day was 2.43 million shares.
Currently, the market capitalization of Sabra Health Care REIT, Inc. The company's current price-earnings ratio amounts to 16.43 times earnings, below the average P/E ratio of 33.54 times earnings.
Additionally on 8/17/16 Citigroup "Maintained" Sabra REIT (NASDAQ:SBRA) to Neutral setting price target at $24 and on 7/25/16 Bank of America "Downgrades" the stock to Underperform.
According to analysts Sabra REIT (NASDAQ:SBRA)'s minimum EPS for the current quarter is at $0.25 and can go high up to $0.44. The institutional investor owned 3,893 shares of the real estate investment trust's stock after buying an additional 1,191 shares during the period.
Here is the rundown on market activity for Sabra Healthcare REIT, Inc. The company had revenue of $62.65 million for the quarter, compared to analysts' expectations of $63.47 million. The company's past year sales total was 55300.
Israel reduces power supply to Hamas-ruled Gaza
The cut will reduce the mains power flow to Gaza to as little as two hours a day, though many businesses and the wealthy have their own generators.
Sabra Healthcare REIT (NASDAQ:SBRA) last announced its earnings results on Monday, May 8th. Stockholders of record on Thursday, May 18th were issued a dividend of $0.43 per share. This represents a $1.72 dividend on an annualized basis and a dividend yield of 7.27%.
Now the P/E of Sabra Health Care REIT, Inc. stands at 16.23. The ex-dividend date was Tuesday the 16th of May 2017. Looking at this figure it suggests that the shares of Sabra Health Care REIT, Inc.
SBRA has been the topic of several recent analyst reports. On average, equities analysts expect that Sabra Healthcare REIT will post $1.20 earnings per share for the current fiscal year. Cantor Fitzgerald reiterated a "buy" rating and set a $30.00 price objective on shares of Sabra Healthcare REIT in a report on Monday, May 8th. Sabra Healthcare REIT has an average rating of "Hold" and a consensus price target of $27.71.
The following firms have also recently changed their position in SBRA. As of quarter end Macquarie Group Ltd had bought a total of 8,300 shares growing its position 70.3%. Ltd. now owns 41,590 shares of the real estate investment trust's stock worth $1,047,000 after buying an additional 600 shares during the last quarter. State Street Corp now owns 1,572,817 shares of the real estate investment trust's stock valued at $38,406,000 after buying an additional 167,688 shares in the last quarter. State Street Corp boosted its position in shares of Sabra Healthcare REIT by 11.9% in the fourth quarter. The real estate investment trust reported $0.25 earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of $0.58 by $0.33.
TRADEMARK VIOLATION WARNING: This article was originally published by Markets Daily and is the property of of Markets Daily. If you are accessing this piece of content on another site, it was illegally stolen and reposted in violation of U.S. & worldwide trademark & copyright laws.
Sabra Healthcare REIT (NASDAQ SBRA) opened at 23.39 on Thursday. It is positive, as 21 investors sold Sabra Health Care REIT Inc shares while 56 reduced holdings. The Company, through its subsidiaries, owns and invests in real estate serving the healthcare industry. The Company's primary business consists of acquiring, financing and owning real estate property to be leased to third-party tenants in the healthcare sector.